Clinical Trial
- Subject 80 elderly male or female participants aged 20–70 years, with ALT level 45~135 U/L and AST level 25 U/L or higher in the previous 2 weeks
-
Method
Take Himalca™(Centella Asiatica extract) 300 mg/day for 180 days
A Randomized, Double-Blind, Placebo-Controlled Parallel Study
-
Before (Placebo)
-
After (Placebo)
-
Before (Himalca™)
-
After (Himalca™)
-
ALT decreased 36.7%
AST decreased 27%
GGT decreased 18.8%
-
Lipid metabolism-related markers
TG and TC significantly decreased
Appl. Sci. 2021, 11, 11498.